Trial Profile
Effects of sodium-glucose co-transporter2(SGLT2) inhibitors on left ventricular systolic and/or diastolic dysfunction in Japanese type2 diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Jan 2017 New trial record